Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Julio Fernandez
Columbia Univ New York Morningside, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Luigs & Neumann
Other : Royalties received through the institution
Dr. Fernandez is entitled to receive an inventor’s share of license fees and royalties through a license from Columbia University to Luigs & Neumann. (Columbia’s Policy on Financial Conflicts of Interest and Research includes royalties above (b)(4), even if received through the University, in the definition of “significant financial interest.”) He received his first payments under the license ((b)(4)) in 2013. Dr. Fernandez continues to conduct research that includes spectroscopy technology related to the licensed technology. In light of these facts, Columbia has determined that the outcome of this research could affect the company and Dr. Fernandez’s royalty interest in the company, and that the design, conduct, and/or reporting of this research could be affected by this financial interest.
The FCOI Committee found the risk of bias to the research relatively low in light of the easy verifiability of instrument results, and separate market validation of any licensed technology, but still determined there to be a conflict that warrants some management.
Single molecule studies of titin elasticity
The giant protein titin is responsible for the elasticity of heart muscle. Genetic mutations of the titin gene cause dilated cardiomyopathies, one the most common types of heart muscle diseases. We will use advanced single molecule techniques to uncover the molecular targets of physiological regulation of titin elasticity. Based on our finding, we will develop the first full-scale model of titin, which can be used to predict the severity of diseases resulting from abnormal cellular regulation and from genetic mutations in the titin gene.
Filed on July 30, 2014.
Tell us what you know about Julio Fernandez's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Julio Fernandez filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Julio Fernandez | Columbia Univ New York Morningside | Conflict of Interest | Luigs & Neumann | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.